We’re building a Commons so that patients, physicians, and scientists can seamlessly learn and benefit from the latest outcomes of innovative treatments
Advanced cancer is personal, but you don’t have to face it alone. Our experts review your medical records and work with you to find your best treatment options
News & Events
Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.” On Monday, Jan 25, at 1pm PST, Marty will engage with other distinguished panelists in an exploration of how to… Read more »
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals, often via a “molecular tumor board” model that precisely matches patients to… Read more »
This month, Cancer Commons earned the 2020 Platinum Seal of Transparency from GuideStar, a database that helps the public evaluate the performance of all nonprofits in the U.S. The Platinum Seal of Transparency is the highest level of recognition offered by GuideStar. To reach the Platinum level, Cancer Commons added extensive information to our profile on GuideStar: basic contact and… Read more »
Our network brings together leading cancer experts, including physicians, clinical researchers, and laboratory scientists
Absolutely wonderful!! Matt is a wealth of knowledge and so prompt at getting back to emails and reporting findings or results. It really is incredible to have this resource free of charge as a second opinion, and gives me comfort knowing what we are doing is the best we can do for now, leaving no stone unturned. We appreciate Cancer... Read more »
Daughter of a grade IV glioblastoma patient
Now is the time to be very actively involved in your own care.
Tony Blau, MD
University of Washington
I’d already been leaning heavily towards a decision, and Emma helped me achieve the final decision…But Emma’s more than a scientist. She is a caring person.
Breast cancer patient
I learned more about my trial options from Emma in a week than I did in 3 years of previous care. Every metastatic patient should know about Cancer Commons. And I love how they use the data to speed up the N-of-1 success stories.
You’re not alone. Cancer Commons is a great resource and sounding board to ask questions and get advice and support.
Advanced breast cancer patient